Cargando…
Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia
Extrapontine myelinolysis (EPM) is a rare symmetrical demyelinating disease of the central nervous system, which is often accompanied with central pontine myelinolysis (CPM) or can appear alone. A combination of flupentixol and melitracen is used as an antianxiety–antidepressant drug which may induc...
Autores principales: | Zhao, Zhihong, Han, Lu, Zhu, Zilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618675/ https://www.ncbi.nlm.nih.gov/pubmed/37920206 http://dx.doi.org/10.3389/fphar.2023.1266296 |
Ejemplares similares
-
Melitracen and flupentixol (deanxit) use disorder in Lebanon
por: El Zahran, Tharwat, et al.
Publicado: (2023) -
Central and Extrapontine Myelinolysis
por: Noukoua, Charlemagne
Publicado: (2016) -
Diagnosis: Osmotic myelinolysis (central pontine myelinolysis and extrapontine myelinolysis)
por: Ahmed, Asrar, et al.
Publicado: (2007) -
The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis
por: Zhou, Xiaoqian, et al.
Publicado: (2019) -
Neuropsychological Findings of Extrapontine Myelinolysis without Central Pontine Myelinolysis
por: Seok, Jung Im, et al.
Publicado: (2007)